Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0050 (-16.67%)
Apr 1, 2025, 3:37 PM EST

Syros Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
120373202497293
Upgrade
Market Cap Growth
-29.54%179.01%-64.05%-59.37%69.48%56.45%
Upgrade
Enterprise Value
3153-108101451206
Upgrade
Last Close Price
0.037.793.5932.60108.5069.10
Upgrade
PS Ratio
2.4620.394.888.6032.93147.97
Upgrade
PB Ratio
-5.1812.160.572.375.493.70
Upgrade
P/TBV Ratio
-12.160.572.375.493.70
Upgrade
EV/Sales Ratio
6.8515.38-4.2929.86104.14
Upgrade
Debt / Equity Ratio
-5.413.730.500.770.730.33
Upgrade
Asset Turnover
0.000.050.070.120.080.02
Upgrade
Quick Ratio
2.053.806.634.236.164.75
Upgrade
Current Ratio
2.253.956.874.346.244.87
Upgrade
Return on Equity (ROE)
-776.96%-227.95%-88.90%-98.49%-99.02%-95.63%
Upgrade
Return on Assets (ROA)
-59.88%-38.32%-36.95%-31.37%-28.32%-37.85%
Upgrade
Return on Capital (ROIC)
-94.28%-58.55%-46.22%-40.46%-39.28%-52.89%
Upgrade
Earnings Yield
-14129.46%-81.23%-130.36%-42.86%-16.91%-25.72%
Upgrade
FCF Yield
-14452.89%-54.29%-171.19%-49.91%-12.21%-24.86%
Upgrade
Buyback Yield / Dilution
-31.77%-124.24%-102.00%-35.79%-14.49%-23.17%
Upgrade
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.